Literature DB >> 16059437

The importance of increased clearance of lamotrigine during pregnancy.

Elinor Ben-Menachem.   

Abstract

Entities:  

Year:  2005        PMID： 16059437      PMCID： PMC1176309          DOI： 10.1111/j.1535-7597.2005.05205.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child.

Authors:  B Rambeck; G Kurlemann; S R Stodieck; T W May; U Jürgens
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.

Authors:  I Ohman; S Vitols; T Tomson
Journal:  Epilepsia       Date:  2000-06       Impact factor: 5.864

3.  Epilepsy and pregnancy: lamotrigine as main drug used.

Authors:  A Sabers; M Dam; B A-Rogvi-Hansen; J Boas; P Sidenius; M Laue Friis; J Alving; M Dahl; J Ankerhus; A Mouritzen Dam
Journal:  Acta Neurol Scand       Date:  2004-01       Impact factor: 3.209

4.  Lamotrigine clearance during pregnancy.

Authors:  T A Tran; I E Leppik; K Blesi; S T Sathanandan; R Remmel
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

5.  Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.

Authors:  Torbjörn Tomson; Emilio Perucca; Dina Battino
Journal:  Epilepsia       Date:  2004-10       Impact factor: 5.864

6.  Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.

Authors:  G-J de Haan; P Edelbroek; J Segers; M Engelsman; D Lindhout; M Dévilé-Notschaele; P Augustijn
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.